Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts
about
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerRegulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-ARegulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblastsIdentification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptorAssociation of insulin receptor substrate 1 with simian virus 40 large T antigenThe insulin-like growth factor-I-mTOR signaling pathway induces the mitochondrial pyrimidine nucleotide carrier to promote cell growthMystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growthThe ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translationMechanisms of Progranulin Action and Regulation in Genitourinary CancersUnderstanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentWild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor genePlasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern SwedenETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylationRole of pescadillo in the transformation and immortalization of mammalian cellsEnhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic miceTwo novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signalingGLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocystInteractions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomasEffects of mutations in the insulin-like growth factor signaling system on embryonic pancreas development and beta-cell compensation to insulin resistanceCartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferationThe adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblastsRILM: a web-based resource to aid comparative and functional analysis of the insulin and IGF-1 receptor family.Progressive loss of SIRT1 with cell cycle withdrawal.Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells.Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near futureInsulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells.BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cellsDecorin differentially modulates the activity of insulin receptor isoform A ligands.Contribution of residue B5 to the folding and function of insulin and IGF-I: constraints and fine-tuning in the evolution of a protein family.Metformin: a therapeutic opportunity in breast cancer.Protein kinase C-delta is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation.Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway.IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood.Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis.Role of receptor tyrosine kinases and their ligands in glioblastoma.IGF-I receptor signalling in transformation and differentiation.Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists.Targeting insulin-like growth factor axis in hepatocellular carcinoma.The contradictions of the insulin-like growth factor 1 receptor.ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis.
P2860
Q21328702-AF8CF531-772D-4B1E-9099-57F8879BD5B6Q24291556-808E1801-12DB-46EA-B435-DD4489059B72Q24292424-9F3FABE7-BF12-40D6-BED9-10C2C81D6868Q24306866-EAEE84F0-309F-406B-8D31-AA3A30973BE1Q24307564-8E62E794-92FA-4405-8ED1-6B70B1255F7FQ24314865-CA2FE386-ACE4-4928-AEC3-52A5AEF0C0D7Q24521364-DEE8CBAA-DE0C-468F-BC73-6F7008F0EF31Q24794247-1084FE57-FF2A-4242-9152-95602E3A013AQ26741917-2188B9A7-78D0-4BB7-A193-6CB14F734659Q26798408-C0B95795-A328-41C8-A686-2FA9D7F4F23BQ28118453-48499F97-0D9F-4B40-9E29-D851AEF4B3A4Q28214565-7D43CBD8-1A7D-4AF4-AC31-2CAEE4277BDBQ28217452-F5DEF78E-7770-40F1-89E6-C678D247C001Q28273765-364090C6-F675-4A89-B811-3BCA499BDE8FQ28377637-207E998C-79DB-43D1-8A48-52841BC69E8BQ28505191-10DF4FA4-60AF-40CE-9439-3A16B9CDAA33Q28510376-7E32437B-E5B1-4C3B-BB4A-DFDD6751EA10Q28510774-52EAF136-02BB-42C0-B8F4-5DD22C37A6F2Q28512935-04209438-7F07-4253-A99C-BEE0A1CDBE37Q28569341-D47E4D62-F76F-4F06-8D1F-3349D43F8684Q28591965-9006E572-8F96-40AF-8D14-D61137CECB26Q30360015-0EDD5A2B-7717-4B45-9EBA-7F8F590CBD37Q30441451-F4A7E93A-BD79-44A2-98B5-284543645B6DQ31078386-2EA268A5-82AC-44D4-9214-9A71EBBF42C4Q33599713-8367D562-D0CC-4562-8239-3F2F431ABEDFQ33636341-481E69DB-8745-410E-8813-271E750C3C99Q33642235-3662D917-8479-461E-8A35-7EA8EB244298Q33690540-CF8CB880-53D2-4CA5-B6CE-84CA45CF8F17Q33717728-EE93566A-D15D-4FD2-8852-BDBEE8F3DD79Q33733319-F9B84D28-AB4A-42A7-B309-4C6A08277EECQ33780757-ECDF1008-97E3-42AC-90EA-7B32E472CB9AQ33818946-9C41A417-5B33-4E6F-A12D-CB41CA51D233Q33839585-B9F823C6-020D-4FB6-9AD6-013E833FC774Q33868752-55E86F3B-34B4-41CB-9E2C-9A3CE8B3DD93Q33883849-F3D18551-E014-48A2-96E1-B140D2C347AFQ33918687-9FA38F42-0B5A-48EB-8FFC-64D487C6A9B8Q33930196-2B10FE61-8D6B-449C-BF47-1331760DC03BQ33951057-F5500594-0406-4F73-B59D-C4A7284FD6D5Q34103628-B7548243-EBEC-4EA4-8E15-AF7E3181D663Q34133760-B887911D-D88F-4C6B-993A-6581B7C85F23
P2860
Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Effect of a null mutation of t ...... on of mouse embryo fibroblasts
@ast
Effect of a null mutation of t ...... on of mouse embryo fibroblasts
@en
type
label
Effect of a null mutation of t ...... on of mouse embryo fibroblasts
@ast
Effect of a null mutation of t ...... on of mouse embryo fibroblasts
@en
prefLabel
Effect of a null mutation of t ...... on of mouse embryo fibroblasts
@ast
Effect of a null mutation of t ...... on of mouse embryo fibroblasts
@en
P2093
P2860
P356
P1476
Effect of a null mutation of t ...... on of mouse embryo fibroblasts
@en
P2093
A Efstratiadis
T DeAngelis
P2860
P304
P356
10.1128/MCB.14.6.3604
P407
P577
1994-06-01T00:00:00Z